Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID)
- PMID: 2668130
- PMCID: PMC1434265
- DOI: 10.1136/gut.30.7.983
Development and validation of an endoscopic index of the severity for Crohn's disease: a prospective multicentre study. Groupe d'Etudes Thérapeutiques des Affections Inflammatoires du Tube Digestif (GETAID)
Abstract
The aim of this study was to develop and validate an endoscopic index for assessing the severity of Crohn's disease. Endoscopic findings were prospectively collected by a multicentre group in 75 patients with Crohn's colitis according to a previously validated procedure. The presence of nine preselected lesions was recorded in the following segments (1) rectum, (2) sigmoid and left colon, (3) transverse colon, (4) right colon, and (5) ileum. In addition the extent of the diseased and ulcerated areas were estimated in each segment. These segmental data were recorded on a standard form, together with the endoscopist's global estimate of lesion severity. A stepwise multiple regression was used to derive an index which was correlated with the endoscopist's global evaluation of lesion severity. Four mucosal lesions: deep and superficial ulcerations, ulcerated and non-ulcerated stenosis, and both estimates of extent involved were selected and weighted to obtain a Crohn's Disease Endoscopic Index of Severity which correlated with the endoscopist's global appraisal of lesion severity (r = 0.83). This index was then prospectively shown to be valid in a further series of 113 colonoscopies (r = 0.81). The index was calculated in 54 patients with active Crohn's disease, before and at the end of a course of corticosteroids: index variations correctly reflected changes in colitis severity as evaluated by the endoscopists (r = 0.72). For endoscopists familiar with the data collection procedure, this Crohn's Disease Endoscopic Index of Severity should be of value in the follow up of patients, especially in clinical trials.
Similar articles
-
Reproducibility of colonoscopic findings in Crohn's disease: a prospective multicenter study of interobserver variation. Groupe d'Etudes Therapeutiques des Affections Inflammatoires du Tube Digestif (GETAID).Dig Dis Sci. 1987 Dec;32(12):1370-9. doi: 10.1007/BF01296663. Dig Dis Sci. 1987. PMID: 3319454 Clinical Trial.
-
Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn's disease. A prospective multicentre study of 121 cases. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives.Gut. 1994 Feb;35(2):231-5. doi: 10.1136/gut.35.2.231. Gut. 1994. PMID: 7508411 Free PMC article.
-
Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Thérapeutique des Affections Inflammatoires Digestives.Gastroenterology. 1990 Apr;98(4):811-8. doi: 10.1016/0016-5085(90)90002-i. Gastroenterology. 1990. PMID: 2179031 Clinical Trial.
-
Colonoscopic findings in Crohn's disease--reproducible, but of questionable benefit.Can J Gastroenterol. 1996 Oct;10(6):405-12. doi: 10.1155/1996/353967. Can J Gastroenterol. 1996. PMID: 9193778 Review.
-
Definition and evaluation of mucosal healing in clinical practice.Dig Liver Dis. 2013 Dec;45(12):969-77. doi: 10.1016/j.dld.2013.06.010. Epub 2013 Aug 7. Dig Liver Dis. 2013. PMID: 23932331 Review.
Cited by
-
Reliability of MR Enterography Features for Describing Fibrostenosing Crohn Disease.Radiology. 2024 Aug;312(2):e233039. doi: 10.1148/radiol.233039. Radiology. 2024. PMID: 39105637
-
Fecal calprotectin and endoscopic scores: The cornerstones in clinical practice for evaluating mucosal healing in inflammatory bowel disease.World J Gastroenterol. 2024 Jun 28;30(24):3022-3035. doi: 10.3748/wjg.v30.i24.3022. World J Gastroenterol. 2024. PMID: 38983953 Free PMC article.
-
IL6 genetic variants haplotype is associated with susceptibility and disease activity but not with therapy response in patients with inflammatory bowel disease.Int J Colorectal Dis. 2021 Feb;36(2):383-393. doi: 10.1007/s00384-020-03743-3. Epub 2020 Oct 12. Int J Colorectal Dis. 2021. PMID: 33047210
-
The Circulating Level of Soluble Receptor for Advanced Glycation End Products Displays Different Patterns in Ulcerative Colitis and Crohn's Disease: A Cross-Sectional Study.Dig Dis Sci. 2015 Aug;60(8):2327-37. doi: 10.1007/s10620-015-3619-7. Epub 2015 Mar 11. Dig Dis Sci. 2015. PMID: 25757448
-
Computed Tomography and Magnetic Resonance Enterography in Crohn's Disease: Assessment of Radiologic Criteria and Endpoints for Clinical Practice and Trials.Inflamm Bowel Dis. 2016 Sep;22(9):2280-8. doi: 10.1097/MIB.0000000000000845. Inflamm Bowel Dis. 2016. PMID: 27508513 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical